Give us a call or provide your contact details below, and a Dentsply Sirona representative will be in touch soon.
Early treatment of gingivitis is key to preventing the development of periodontitis. Additionally, failure to comply with an ongoing periodontal maintenance programme may contribute to the recurrence or progression of the periodontal disease process.
That’s why providing a better patient experience during periodontal therapy is so important.
Oraqix is a non-injectable, pH neutral anaesthetic.
ORAQIX MUST NOT BE INJECTED. Oraqix should not be used in patients with glucose-6-phosphate dehydrogenase deficiency or congenital or idiopathic methemoglobinemia.
This product is not included on the PBS. Product Information should be reviewed prior to prescribing. Further information is available upon request.
Benefits
30 seconds onset and approximately 20 minutes to be effective
on contact and should be dispensed directly into a pocket
Video
Listen to this testimonial by Kim Miller, RDH, BSDH. Kim Miller received her BSDH in 1981 from Loma Linda University. She’s a Lead Profitability Coach with Inspired Hygiene, an international speaker and a monthly columnist for RDH magazine.
Application
Patients with gingivitis and periodontal disease typically have inflamed, irritated tissue. Some manufacturers of competitive topical products limit dose to only 0.4mL of liquid or warn against use on large areas of denuded or inflamed tissue. Check prescribing information prior to purchase.
Oraqix is a non-injectable, pH neutral anaesthetic. Maximum dose is 5 full cartridges (8.5mL), enough to complete a full mouth scaling.
You're being redirected to Dentsply Sirona USA. Are you sure you want to proceed?